Cargando…

Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort Study

Background: The Academic Research Consortium has identified a set of major and minor risk factors in order to standardize the definition of a high bleeding risk (ACR-HBR). Oral anticoagulation is a major criterion frequently observed. Aims: The objective of this study is to quantify the risk of blee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schukraft, Sara, Huwyler, Tibor, Ottiger-Mankaka, Cindy, Lehmann, Sonja, Cook, Ezia, Doomun, Daphné, Doomun, Ianis, Goy, Jean-Jacques, Stauffer, Jean-Christophe, Togni, Mario, Arroyo, Diego, Puricel, Serban, Cook, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514702/ https://www.ncbi.nlm.nih.gov/pubmed/34660705 http://dx.doi.org/10.3389/fcvm.2021.589426

Ejemplares similares

Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions
por: Doomun, Daphné, et al.
Publicado: (2021)

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018)

Is the folk medicine known as “The Secret” efficient in reducing bleeding after percutaneous coronary procedures?: a double-blinded, randomised trial
por: Ferry, Charlie, et al.
Publicado: (2022)

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
por: Arroyo, Diego, et al.
Publicado: (2014)

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

Heart rate never lies: interventional cardiologist and Braude's quote revised
por: Cook, Stéphane, et al.
Publicado: (2016)

A mouth watering case of Mycoplasma salivarium native mitral valve endocarditis: ‘case report’
por: Scheen, Marc, et al.
Publicado: (2023)

Spontaneous Recanalization of Coronary Thrombus in a Patient With Polycythemia Vera
por: Schukraft, Sara, et al.
Publicado: (2020)

Female residents experiencing medical errors in general internal medicine: a qualitative study
por: Mankaka, Cindy Ottiger, et al.
Publicado: (2014)

Handheld ECG Tracking of in-hOspital Atrial Fibrillation (HECTO-AF): A Randomized Controlled Trial
por: Mancinetti, Marco, et al.
Publicado: (2021)

Handheld ECG Tracking of in-hOspital Atrial Fibrillation The HECTO-AF trial Clinical Study Protocol
por: Schukraft, Sara, et al.
Publicado: (2019)

A Simple Method for Measuring Carbon-13 Fatty Acid Enrichment in the Major Lipid Classes of Microalgae Using GC-MS
por: Elahee Doomun, Sheik Nadeem, et al.
Publicado: (2016)

Remote blood pressure monitoring with a wearable photoplethysmographic device in patients undergoing coronary angiography: the senbiosys substudy
por: Schukraft, Sara, et al.
Publicado: (2022)

Understanding Bleeding Risk after Anticoagulation
Publicado: (2005)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants
por: Sarah, Lessire, et al.
Publicado: (2014)

An incidental finding of a bicuspid aortic valve and pseudocoarctation of the descending aorta in a patient presenting with an acute coronary syndrome: a case report
por: Vivekanantham, Hari, et al.
Publicado: (2020)

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”
por: Lessire, Sarah, et al.
Publicado: (2014)

Anticoagulant-related bleeding in patients receiving anticoagulant therapy over 10 years
por: Zhu, Lihong, et al.
Publicado: (2023)

Cardiovascular Manifestations of COVID-19: Insights into a Single-Center Experience
por: Schukraft, Sara, et al.
Publicado: (2021)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Anticoagulation and bleeding risk in patients with COVID-19
por: Musoke, Nancy, et al.
Publicado: (2020)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
por: Samuelson Bannow, Bethany, et al.
Publicado: (2021)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Commentary: To bleed or not to bleed, that is the question—Anticoagulation in surgical patients on prolonged extracorporeal membrane oxygenation
por: Schweiger, Thomas, et al.
Publicado: (2020)

Aminaphtone for Light Bleeding in Patients Under Oral Anticoagulation
por: Pereira de Godoy, José Maria, et al.
Publicado: (2010)

Management of bleeding in patients treated with direct oral anticoagulants
por: Levi, Marcel
Publicado: (2016)

Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed
por: Lioutas, Vasileios‐Arsenios, et al.
Publicado: (2019)

Evaluation of bleeding in patients receiving direct oral anticoagulants
por: Hellenbart, Erika L, et al.
Publicado: (2017)

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

Spontaneous rectal sheath bleed while on DOAC anticoagulation
por: de Courcy, Louis, et al.
Publicado: (2023)

Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding
por: Little, Derek H.W., et al.
Publicado: (2021)

Impact of anticoagulants on the clinical outcomes of colonic diverticular bleeding comparing warfarin and direct oral anticoagulants
por: Chang, Li-sa, et al.
Publicado: (2022)

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
por: Kirchhof, Paulus, et al.
Publicado: (2020)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Recurrent nonbacterial thrombotic endocarditis and stroke on anticoagulation
por: Basnet, Sijan, et al.
Publicado: (2020)

Evaluation the dentists’ awareness of inherited bleeding disorders and anticoagulants in Shiraz
por: Robati, R, et al.
Publicado: (2013)

Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
por: Christos, Steve, et al.
Publicado: (2016)

The Prevention of Bleeding during Long-Term Oral Anticoagulant Therapy
por: Eastham, R. D.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_fo6b71av25s24ffbj086o6buga